Diagnosis and Management of Migraine
BMJ 312:1279-1283, Goadsby,P.J.&Olesen,J., 1996
Serum Cortisol and Cerebrospinal Fluid B-Endorphins in Status Epilepticus:Their Possible Relation to Prognosis
Arch Neurol 50:689-693, Calabrese,V.P.,et al, 1993
Effects of Naloxone in Senile Dementia:A Double-Blind Trial
NEJM 308:721-722, Reisberg,B.,et al, 1983
Acupuncture Relief of Chronic Pain Syndrome Correlates with Increased Plasma Met-Enkephalin Concentra
Lancet 2:1394-1396, Kiser,R.S.,et al, 1983
Acupuncture Treatments for Pain Relief
JAMA 245:768-769, Ulett,G.A., 1981
Pain II:New Approaches to Management
Ann Neurol 9:101-106, Fields,H.L., 1981
Brain Peptides
(part I & II) NEJM 304:876-885, 944-951., Krieger,D.T.&Martin,J.G., 1981
How Does Acupuncture Work? Editorial
BMJ 283:746-748, , 1981
Neuroendocrinology & Brain Peptides
Ann Neurol 8:551-557, Cooper,P.E.,et al, 1980
Hyper-Endorphin Syndrome in a Child With Necrotizing Encephalomyelopathy
NEJM 303:914-916, Brandt,N.J.,et al, 1980
Cortical Evoked Responses & Transcutaneous Electrotherapy
Neurol 30:663-665, Salar,G.,et al, 1980
Opiate Peptides
Analgesia, & the Neuroendocrine System, Editorial, BMJ 1:741-742., , 1980
Pain Sensitivity In Schizophrenics
NEJM 301:946-947, Hoo,J.J.,et al, 1979
Opiate Receptors in the Brain
NEJM 296:266, Snyder,S.H., 1977
A Rare Neurotoxicity Syndrome Following Opioid Intoxication
Ann Neurol 96:412-415, Venkatraman,S.,et al, 2024
Comparative Effects of Drug Interventions for the Acute Management of Migraine Episodes in Adults:Systematic Review and Network Meta-Analysis
BMJ 386:e080107, Karlsson,W.K.,et al, 2024
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
NEJM 391:1193-1205, Malhotra,A.,et al, 2024
Changing Trends in Demographics, Risk Factors, and Clinical Features of Patients with Infective Endocarditis-Related Stroke, 2005-2015
Neurol 100:e1555-e1564, Ridha,M.,et al, 2023
Opioid-Associated Amnestic Syndrome Progressing to Diffuse Leukoencephalopathy
Neurohospitalist 13:109-110, Meng,D., & Randhawa,J., 2023
Atogepant for the Preventive Treatment of Chronic Migraine (PROGRESS): A Randomised, Double-blind, Placebo-controlled, Phase 3 Trial
Lancet 402:775-785, Pozo-Rosich,P.,et al, 2023
Clinicopathologic Conference, Mycobacterium Tuberculosis Meningitis
NEJM 384:166-176, Case 1-2021, 2021
Delayed Cerebral Abscess Formation after Posterior Cerebral Artery Stroke in a Patient with Opioid Use Disorder
Stroke 52:e100-e103, Zuflacht,J.P.& Fehnel,C.R., 2021
Acute Treatment for Migraine
JAMA 325:2346-2347, Burch, R. & Rayhill, M., 2021
Atogepant for the Preventive Treatment of Migraine
NEJM 385:695-706, Ailani,J.,et al, 2021
Bilateral Middle Cerebellar Peduncle Lesions:Neuroimaging Features and Differential Diagnoses
Brain Behav 10:e01778, Jiang,J.,et al, 2020
Clinical and Radiologic Features of Pedicatric Opioid Use-Associated Neurotoxicity with Cerebellar Edema (POUNCE) Syndrome
Neurol 94:710-712, Kim, D.D. & Prasad, A.N., 2020
Clinicopathologic Conference, AA Amyloidosis, Complicated by Cerebral Mucormycosis
NEJM 382:1457-1466, Case 11-2020, 2020
One-Year Sustained Efficacy of Erenumab in Episodic Migraine
Neurol 95:e469-e479, Goadsby, P.J.,et al, 2020
Migraine
NEJM 383:1866-1876, Ashina, M., 2020
"CHOICES": An Acronym to Aid in Delineating Potential Causes of Non-Metabolic, Non-Infectious Acute Toxic Leukoencephalopathy
EJR OPEN 6:243-257, Koksel, Y.,et al, 2019
Acute Toxic Leukoencephalopathy: Etiologies, Imaging Findings, and Outcomes in 101 Patients
AJNR 40:267-275, Ozutemiz, C.,et al, 2019
Erenumab in Chronic Migraine
Neurol 92:e2250-e2260, Lipton, R.B.,et al, 2019
Remigepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine
NEJM 381:142-149, Lipton, R.B.,et al, 2019
Trial of Galcanezumab in Prevention of Episodic Cluster Headache
NEJM 381:132-141, Goadsby, P.J.,et al, 2019
Clinicopathologic Conference, Statin-Associated Autoimmune Myopathy
NEJM 381:275-283, Case 22-2019, 2019
Targeting Calcitonin Gene-Related Peptide: A New Era in Migraine Therapy
Lancet 394:1765-1774, Charles, A. & Pozo-Rosich, P., 2019
Ubrogepant for the Treatment of Migraine
NEJM 381:2230-2241, Dodick, D.W.,et al, 2019
Mystery Case: A 48-year-old Woman with Bizarre Behavior, Neurologic Symptoms, and Progressive Decline
Neurol 90:242-247, Kesari, N.K.,et al, 2018
Neonatal Abstinence Syndrome
JAMA 319:1362-1374, Wachman, E.,et al, 2018
A young woman with symmetric weakness and behavioral disturbance
Neurol 90:e1442-e1447, Rosenberg, J.,et al, 2018
Clinicopathologic Conference, Digitalis Toxicity
NEJM 378:1931-1938, Case 15-2018, 2018
Clinicopathologic Conference, Pulmonary Adenocarcinoma, Complicated by a Hypercoagulable State with a Nonbacterial Thrombotic Endocarditis
NEJM, Case 33-2018, 2018
Preventive Migraine Drug Approved
JAMA 320:1746, , 2018
Efficacy and Tolerability of Erenumab in Patients with Episodic Migraine in Whom Two-of-Four Previous Preventive Treatments were Unsuccessful: A Randomised, Double-Blind, Placebo-Controlled, Phase 3b Study
Lancet 392:2280-2287,2241, Reuter, U.,et al, 2018
Galcanezumab in Chronic Migraine
Neurol 91:e2211-e2221, Detke, H.C.,et al, 2018
Non-Specific Low Back Pain
Lancet 389:736-747, Maher, C.,et al, 2017
A Young Woman with Respiratory Failure, Hearing Loss, and Paraplegia
Neurol 88:e78-e84, Ntranos, A.,et al, 2017
Association of Spinal Manipulative Therapy with Clinical Benefit and Harm for Acute Low Back Pain
JAMA 317:1451-1460,1418, Paige, N.M.,et al, 2017
Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome
NEJM 376:2341-2348, Kraft, W.K.,et al, 2017